Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
Statistics in Medicine · 2025
DOI: 10.1002/sim.70177 ↗At a glance
Journal article in Statistics in Medicine, 2025. Written by Shu Jiang and 2 co-authors. Institution: Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri, USA. Major MEDLINE topics: Research Design, Randomized Controlled Trials as Topic. Cited 1 times so far (Crossref); 31 references. The full text is freely available in PubMed Central. Funded by: NIA NIH HHS, NIH HHS, NINDS NIH HHS.
Abstract (original language)
For many diseases and disorders, such as Alzheimer's disease, patients demonstrate considerable heterogeneity in their responses to treatment interventions. One treatment may be most effective for some patients, while another may be most effective for others, and neither may be effective for another subset of patients. This potentially renders the conventional parallel group design highly inefficient. An attractive alternative is the N‐of‐1 design, also called the multi‐crossover randomized controlled trial. In this design, each participant serves as their own control in a series of randomized blocks of treatment assignments. We propose novel designs for both the single‐person and multi‐person N‐of‐1 trials that employ sequential monitoring. In particular, we allow for early stopping for a single participant as soon as there is sufficient evidence of a preferred treatment for them, and early stopping for the group of participants as soon as there is sufficient evidence of a preferred treatment for the population of patients. We provide sample size calculations and decision rules for terminating the trial early and illustrate their properties in simulation studies. We apply our proposed methods to N‐of‐1 studies of brain tumor excisions and of methylphenidate in mild cognitive impairment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri, USA.
- Massachusetts Interdisciplinary Brain Center, Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
- Department of Biostatistics, New York University School of Global Public Health, New York, New York, USA.
ORCID profiles: Shu Jiang, Rebecca A Betensky
Funding
- NIA NIH HHS
- NIH HHS
- NINDS NIH HHS
- NCATS NIH HHS
- National Institutes of Health
Cite
APA
Jiang, S., Arnold, S. E., & Betensky, R. A. (2025). Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring. Statistics in Medicine. https://doi.org/10.1002/sim.70177
Vancouver
Jiang S, Arnold SE, Betensky RA. Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring. Statistics in Medicine. 2025. doi:10.1002/sim.70177
BibTeX
@article{Jiang2025,
author = {Jiang, Shu and Arnold, Steven E and Betensky, Rebecca A},
title = {Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring},
journal = {Statistics in Medicine},
year = {2025},
doi = {10.1002/sim.70177}
}
EUVIMED